Laboratory of Visceral System Physiology, Institute of Experimental Medicine, St. Petersburg, Russia.
Bull Exp Biol Med. 2023 Jul;175(3):300-303. doi: 10.1007/s10517-023-05856-5. Epub 2023 Aug 10.
Changes of pulmonary microcirculation in response to pulmonary artery embolization after pretreatment with chloroquine were studied on the model of isolated perfused rabbit lungs. The increase in the pulmonary vascular resistance and pre- and postcapillary resistance was less pronounced than after pulmonary thromboembolism after pretreatment with mibefradil (T-type Ca channels blocker) or nifedipine (L-type Ca channels blocker). The shifts of capillary filtration coefficient correlated with changes in the precapillary resistance. When modeling pulmonary thromboembolism after pretreatment with chloroquine combined with glibenclamide (K channels blocker), the studied hemodynamics parameters increased to the same extent as after pretreatment with nifedipine. The results indicate that chloroquine exhibits the properties of an L- and T-type Ca channels blocker and an activator of K channels.
氯喹预处理后肺动脉栓塞对肺微循环的影响在离体灌注兔肺模型上进行了研究。与米贝地尔(T 型钙通道阻滞剂)或硝苯地平(L 型钙通道阻滞剂)预处理后肺血栓栓塞相比,氯喹预处理后肺血管阻力和肺前、后毛细血管阻力的增加不那么明显。毛细血管滤过系数的变化与前毛细血管阻力的变化相关。当氯喹预处理结合格列本脲(K 通道阻滞剂)模拟肺血栓栓塞时,研究的血液动力学参数增加到与硝苯地平预处理相同的程度。结果表明,氯喹具有 L 型和 T 型钙通道阻滞剂以及 K 通道激活剂的特性。